Candida biomarkers in patients with candidaemia and bacteraemia

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 8, 2015, Pages 2354-2361

  Martínez Jiménez, M Carmen ^a   Muñoz, Patricia ^a,b,c   Valerio, Maricela ^a   Alonso, Roberto ^a   Martos, Carmen ^a   Guinea, Jesús ^a,b   Bouza, Emilio ^a,b,c  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c SCHOOL OF MEDICINE   (Spain)

Author keywords

Antifungal therapy; Diagnosis; Stop; Unnecessary antifungals

Indexed keywords

ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; FUNGUS ANTIBODY; FUNGUS ANTIGEN;

ABDOMINAL SURGERY; ACCURACY; ACINETOBACTER BAUMANNII; AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BLOOD CULTURE; BLOODSTREAM INFECTION; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; CANDIDIASIS; DRUG USE; ENTEROCOCCUS FAECALIS; FEMALE; FUNGAL COLONIZATION; FUNGEMIA; HUMAN; INTRAVENOUS CATHETER; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PICHIA KUDRIAVZEVII; PREDICTIVE VALUE; PSEUDOMONAS AERUGINOSA; SENSITIVITY AND SPECIFICITY; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TOTAL PARENTERAL NUTRITION; ADULT; BLOOD; CHEMISTRY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; PROCEDURES; SPAIN; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; BACTEREMIA; BIOMARKERS; CANDIDA; CANDIDEMIA; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SPAIN;

EID: 84939480671     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv090     Document Type: Article

References (30)

1. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005; 49: 3640-5.
2. Valerio M, Rodriguez-Gonzalez CG, Munoz P et al. Evaluation of antifungal use in a tertiary care institution: antifungal stewardship urgently needed. J Antimicrob Chemother 2014; 69: 1993-9.
3. Lopez-Medrano F, San Juan R, Lizasoain M et al. A non-compulsory stewardship programme for the management of antifungals in a university-affiliated hospital. Clin Microbiol Infect 2013; 19: 56-61.
4. Leon C, Ostrosky-Zeichner L, Schuster M. What's new in the clinical and diagnostic management of invasive candidiasis in critically ill patients. Intensive Care Med 2014; 40: 808-19.
5. Clancy CJ, Nguyen MH. Finding the 'missing 50%' of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis 2013; 56: 1284-92.
6. Horvath LL, George BJ, Hospenthal DR. Detection of fifteen species of Candida in an automated blood culture system. J Clin Microbiol 2007; 45: 3062-4.
7. Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence 2013; 4: 119-28.
8. Tissot F, Lamoth F, Hauser PM et al. β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis. Am J Respir Crit Care Med 2013; 188: 1100-9.
9. Held J, Kohlberger I, Rappold E et al. Comparison of (1rarr;3)-β-d-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia. J Clin Microbiol 2013; 51: 1158-64.
10. Peman J, Zaragoza R, Quindos G et al. Clinical factors associated with a Candida albicans germ tube antibody positive test in intensive care unit patients. BMC Infect Dis 2011; 11: 60.
11. Cuenca-Estrella M, Verweij PE, Arendrup MC et al. ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect 2012; 18 Suppl 7: 9-18.
12. Marchetti O, Lamoth F, Mikulska M et al. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transplant 2012; 47: 846-54.
13. Llinares Mondéjar PZCR, Maseda Garrido E, Ferrer Roca R et al. EPICO PROJECT. Development of educational recommendations using the DELPHI technique on invasive candidiasis in non-neutropenic critically ill adult patients. Rev Esp Quimioter 2013; 26: 131-50.
14. Alothman AF, Al-Musawi T, Al-Abdely HM et al. Clinical practice guidelines for the management of invasive Candida infections in adults in theMiddle East region: expert panel recommendations. J Infect Public Health 2014; 7: 6-19.
15. Saville SP, Lazzell AL, Monteagudo C et al. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell 2003; 2: 1053-60.
16. Martinez-Jimenez MC, Munoz P, Guinea J et al. Potential role of Candida albicans germ tube antibody in the diagnosis of deep-seated candidemia. Med Mycol 2014; 52: 270-5.
17. Brissaud O, Guichoux J, Harambat J et al. Invasive fungal disease in PICU: epidemiology and risk factors. Ann Intensive Care 2012; 2: 6.
18. Posteraro B, De Pascale G, Tumbarello M et al. Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-d-glucan assay, Candida score, and colonization index. Crit Care 2011; 15: R249.
19. Mohr JF, Sims C, Paetznick V et al. Prospective survey of (1rarr;3)-β-d-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting. J Clin Microbiol 2011; 49: 58-61.
20. Delaloye J, Calandra T. Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence 2014; 5: 161-9.
21. Sulahian A, Porcher R, Bergeron A et al. Use and limits of (1-3)-bd-glucan assay (Fungitellw), compared to galactomannan determination (Platelia Aspergillus) for diagnosis of invasive aspergillosis. J Clin Microbiol 2014; 52: 2328-33.
22. Theel ES, Doern CD. β-d-Glucan testing is important for diagnosis of invasive fungal infections. J Clin Microbiol 2013; 51: 3478-83.
23. Prella M, Bille J, Pugnale M et al. Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies. Diagn Microbiol Infect Dis 2005; 51: 95-101.
24. Mikulska M, Calandra T, Sanguinetti M et al. The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. Crit Care 2010; 14: R222.
25. Morrissey CO. Advancing the field: evidence for new management strategies in invasive fungal infections. Curr Fungal Infect Rep 2013; 7: 51-8.
26. Sendid B, Caillot D, Baccouch-Humbert B et al. Contribution of the Platelia Candida-specific antibody and antigen tests to early diagnosis of systemic Candida tropicalis infection in neutropenic adults. J Clin Microbiol 2003; 41: 4551-8.
27. Ellis M, Al-Ramadi B, Bernsen R et al. Prospective evaluation of mannan and anti-mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever. J Med Microbiol 2009; 58: 606-15.
28. Nguyen MH, Wissel MC, Shields RK et al. Performance of Candida realtime polymerase chain reaction, β-d-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis 2012; 54: 1240-8.
29. Ayats J, Martin-Mazuelos E, Peman J et al. [Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) guidelines for the diagnosis of invasive fungal infections. 2010 update]. Enferm Infecc Microbiol Clin 2011; 29: 39.e1-15.
30. Racil Z, Kocmanova I, Lengerova M et al. Difficulties in using 1, 3-β-d-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies-high frequency of false-positive results and their analysis. J Med Microbiol 2010; 59: 1016-22.